[go: up one dir, main page]

AU3373300A - Method of modifying cytotoxic cells and uses thereof - Google Patents

Method of modifying cytotoxic cells and uses thereof

Info

Publication number
AU3373300A
AU3373300A AU33733/00A AU3373300A AU3373300A AU 3373300 A AU3373300 A AU 3373300A AU 33733/00 A AU33733/00 A AU 33733/00A AU 3373300 A AU3373300 A AU 3373300A AU 3373300 A AU3373300 A AU 3373300A
Authority
AU
Australia
Prior art keywords
modifying
cytotoxic cells
cytotoxic
cells
modifying cytotoxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33733/00A
Inventor
Alessandra Cesano
Giovanni Rovera
Daniela Santoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU3373300A publication Critical patent/AU3373300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU33733/00A 1999-02-24 2000-02-23 Method of modifying cytotoxic cells and uses thereof Abandoned AU3373300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12148299P 1999-02-24 1999-02-24
US60121482 1999-02-24
PCT/US2000/004548 WO2000050569A1 (en) 1999-02-24 2000-02-23 Method of modifying cytotoxic cells and uses thereof

Publications (1)

Publication Number Publication Date
AU3373300A true AU3373300A (en) 2000-09-14

Family

ID=22397001

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33733/00A Abandoned AU3373300A (en) 1999-02-24 2000-02-23 Method of modifying cytotoxic cells and uses thereof

Country Status (3)

Country Link
EP (1) EP1155115A4 (en)
AU (1) AU3373300A (en)
WO (1) WO2000050569A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2953434T3 (en) 2009-08-24 2023-11-13 Baylor College Medicine Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
PT2812431T (en) 2012-02-09 2019-10-18 Baylor College Medicine PEPMIXES TO GENERATE MULTIVIRAL CTLS WITH WIDE SPECIFICITY
CN113943703A (en) * 2015-09-18 2022-01-18 贝勒医学院 Identification of immunogenic antigens from pathogens and correlation with clinical efficacy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683690A (en) * 1992-03-30 1997-11-04 The Wistar Institute Of Anatomy And Biology Modified cytotoxic tall cell line and compositions and methods for manufacture and use thereof as therapeutic reagents for cancer
US5702702A (en) * 1992-03-30 1997-12-30 The Wistar Institute Of Anatomy And Biology Modified cytotoxic tall cell line and compositions and methods for manufacture and use thereof as therapeutic reagents for cancer
US5820856A (en) * 1992-03-30 1998-10-13 The Wistar Institute Of Anatomy And Biology Modified TALL-104 cells to treat cancer
ES2171169T3 (en) * 1993-05-14 2002-09-01 Wistar Inst USE OF MODIFIED TALL-104 CELLS TO TREAT CANCER AND VIRAL DISEASES.
DE69425906T2 (en) * 1994-04-06 2001-03-29 Immunex Corp., Seattle INTERLEUKIN-15

Also Published As

Publication number Publication date
EP1155115A4 (en) 2002-03-27
WO2000050569A1 (en) 2000-08-31
EP1155115A1 (en) 2001-11-21

Similar Documents

Publication Publication Date Title
AU6746800A (en) Carbon-reinforced electrode and method of making same
AU3985200A (en) Functionally improved battery and method of making same
AU5166500A (en) Interposer and method of making same
AU8007000A (en) Integrated forms and method of making such forms
AU2000273206A1 (en) Photocatalyst-bearing material and method of producing the same
AU2867200A (en) Cap body jewelry and method of making same
AU1169001A (en) Ferrofluid composition and process
AU715620C (en) Therapeutic methods and uses
AU4829400A (en) Battery grid and method of making
AU6421600A (en) Compacted-powder opposed twin-helical gears and method
AU3553400A (en) Use and production of polypropylene
AU2786100A (en) Method of selecting transformed cells and tissues
AU5116100A (en) Connector and method of use of the connector
AU1812601A (en) Cover member and method of making same
AU1083501A (en) Antibiotic-metal complex and methods
AU1220599A (en) Method for the production and use of dendritic cells
AU3373300A (en) Method of modifying cytotoxic cells and uses thereof
AU7372900A (en) Electrochemical cell having beaded can and method of forming same
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU1314601A (en) Implements and methods of manufacturing same
AU1567301A (en) Tablets comprising micro-organisms and method for preparation of the tablets
AU5979300A (en) Angiopoietin-6 and uses thereof
AU1330301A (en) Canelo products and methods of making and using same
AU4306301A (en) Zinc-containing powders and methods of manufacture
AU1477601A (en) Genetic compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase